Moderna
MRNA
#1116
Rank
HK$157.89 B
Marketcap
HK$398.15
Share price
5.33%
Change (1 day)
80.48%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : HK$28.90 Billion

According to Moderna 's latest financial reports the company's total liabilities are HK$28.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$28.69 B14.04%
2024-12-31HK$25.16 B-29.53%
2023-12-31HK$35.70 B-32.14%
2022-12-31HK$52.62 B-35.87%
2021-12-31HK$82.06 B121.64%
2020-12-31HK$37.02 B1046.61%
2019-12-31HK$3.22 B-4.53%
2018-12-31HK$3.38 B-5.73%
2017-12-31HK$3.58 B-19.58%
2016-12-31HK$4.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$922.20 B 3,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$504.73 B 1,646.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$659.94 B 2,183.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$45.44 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.34 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$32.73 B 13.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$8.16 B-71.76%๐Ÿ‡บ๐Ÿ‡ธ USA